Advanced analytics can extract enormous value from your LIMS. Find out how LabVantage Analytics solves the challenges of data access, visibility, volume, and speed for complete data views and endless insights.
Thursday, August 26, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST This webcast will explore the benchmark practices for rapid progression from first-in-human to large-scale commercial manufacture for microdosing API. Micro-dosing at a commercial scale made effortless.
This article examines IVBE testing requirements for topical creams and explores some of the analytical techniques necessary.
This article examines IVBE testing requirements for topical creams and explores some of the analytical techniques necessary.
An architect's evaluation early in a pharmaceutical facility relocation and design process can help identify potential problems.
Preventing contamination during routine cleaning operations requires particle-free cleaning equipment to maintain specific airborne particle levels.
Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.
Materials used in the seals of split butterfly valves for aseptic pharmaceutical manufacturing should be chosen carefully.
This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
This article presents considerations for preventing hazards associated with dust in pharmaceutical production, particularly as relates to the United Kingdom's Control of Substances Hazardous to Health (COSHH) Regulations.
Case studies compare efficacy testing of preservatives for topical formulations with probiotic actives.
Case studies compare efficacy testing of preservatives for topical formulations with probiotic actives.
Case studies compare efficacy testing of preservatives for topical formulations with probiotic actives.
Manufacturers are facing ever-increasing competition while end users are expecting better value and efficacy. The authors discuss these challenges and offer practical solutions.
Twenty-first century drug development challenges sponsors and contract partners to collaborate more closely, using tools such as model-based simulation.
The performance of nanoparticles used as carriers in drug delivery is intimately linked to their physical properties. Nanoprecipitation is a common method for the preparation of drug-loaded polymer nanoparticles, but until recently, the reproducibility of the two primary dimensional descriptors-the average particle size and the breadth of the size distribution-has been a challenge due to the intrinsic variability of batch processes. Microfluidics-based flow techniques, however, reduce variation in drug-loaded polymer nanoparticle synthesis.
Tableting instruments (i.e., compaction simulators) that simulate high-speed presses can be used in a quality-by-design (QbD) approach to perform in-depth material characterization and direct scale-up.
Advanced data analytics tools are used by industry to find the golden nuggets in historical data, to aid in process development, to fine-tune production, and to achieve long-term improvements in product quality and throughput.
Advanced data analytics tools are used by industry to find the golden nuggets in historical data, to aid in process development, to fine-tune production, and to achieve long-term improvements in product quality and throughput.
Machine vision and optical character recognition technologies enhance inspection of packages and labels.
Aston Particle Technologies has developed a technology that produces functionalized particles in a one-step, environmentally friendly process.
Drug manufacturers can improve use of quality agreements in contract manufacturing.
Aston Particle Technologies has developed a technology that produces functionalized particles in a one-step, environmentally friendly process.
Drug manufacturers can improve use of quality agreements in contract manufacturing.